comparemela.com

Marks Levine News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Short Interest in Immunovant, Inc (NASDAQ:IMVT) Increases By 5 3%

Immunovant, Inc. (NASDAQ:IMVT – Get Free Report) saw a significant growth in short interest in the month of April. As of April 30th, there was short interest totalling 8,960,000 shares, a growth of 5.3% from the April 15th total of 8,510,000 shares. Based on an average daily volume of 1,130,000 shares, the short-interest ratio is […]

China Universal Asset Management Co Ltd Purchases 13,374 Shares of Immunovant, Inc (NASDAQ:IMVT)

China Universal Asset Management Co Ltd Purchases 13,374 Shares of Immunovant, Inc (NASDAQ:IMVT)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

China Universal Asset Management Co Ltd Grows Position in Immunovant, Inc (NASDAQ:IMVT)

China Universal Asset Management Co Ltd Grows Position in Immunovant, Inc (NASDAQ:IMVT)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Fred Alger Management LLC Raises Stake in Immunovant, Inc (NASDAQ:IMVT)

Fred Alger Management LLC Raises Stake in Immunovant, Inc (NASDAQ:IMVT)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Immunovant, Inc (NASDAQ:IMVT) Insider Sells $77,144 10 in Stock

Immunovant, Inc. (NASDAQ:IMVT – Get Free Report) insider Mark S. Levine sold 2,134 shares of the stock in a transaction that occurred on Thursday, February 22nd. The shares were sold at an average price of $36.15, for a total transaction of $77,144.10. Following the sale, the insider now owns 301,968 shares in the company, valued […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.